Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,702 | -478,572 | -327,308 | -174,248 | -69,851 |
| Depreciation Amortization | 4,344 | 10,793 | 7,554 | 4,616 | 2,199 |
| Accounts receivable | 133 | -2,280 | -2,434 | -1,039 | 879 |
| Accounts payable and accrued liabilities | 21,186 | 9,006 | 24,236 | 8,818 | -9,788 |
| Other Working Capital | 19,719 | -1,101 | 12,154 | 904 | -12,275 |
| Other Operating Activity | -68,079 | 151,966 | 73,957 | 25,078 | 15,158 |
| Operating Cash Flow | $-98,400 | $-310,189 | $-211,842 | $-135,872 | $-73,678 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,018 | 300,483 | 155,068 | N/A | N/A |
| PPE Investments | -17,773 | -18,846 | -14,409 | -12,152 | -6,775 |
| Purchase Of Investment | -47,554 | -614,274 | -397,917 | -257,047 | N/A |
| Investing Cash Flow | $-36,309 | $-332,637 | $-257,258 | $-269,199 | $-6,775 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,390 | 729,698 | 733,184 | 10,985 | N/A |
| Other Financing Activity | -2,365 | -41,291 | -40,743 | -2,539 | -1,232 |
| Financing Cash Flow | $24 | $688,407 | $692,441 | $8,445 | $-1,232 |
| Exchange Rate Effect | 26,820 | -61,104 | -30,049 | 2,982 | 11,384 |
| Beginning Cash Position | 704,694 | 683,217 | 699,186 | 658,575 | 659,831 |
| End Cash Position | 596,829 | 667,694 | 892,478 | 264,930 | 589,529 |
| Net Cash Flow | $-107,865 | $-15,523 | $193,292 | $-393,644 | $-70,301 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,400 | -310,189 | -211,842 | -135,872 | -73,678 |
| Capital Expenditure | -5,492 | -24,619 | -19,090 | -12,152 | -6,775 |
| Free Cash Flow | -103,891 | -334,808 | -230,931 | -148,024 | -80,453 |